Atherosclerosis and Cardiovascular Research · Annual Conference
BAS Annual Meeting 2026
Organised by the British Atherosclerosis Society
Dates10–11 Sept 2026
VenueWorcester College, Walton Street, Oxford OX1 2HB
CityOxford, United Kingdom
The British Atherosclerosis Society annual meeting in Oxford, themed around new branches in atherosclerosis research from discovery to intervention, with oral and poster abstract opportunities and a broad cardiovascular research programme.
Audience
BAS members, cardiovascular researchers, lipid and atherosclerosis scientists, clinician academics and early-career investigators.
Networking
The programme includes trade exhibition, poster sessions, a Young Scientist Community session and optional dinner/accommodation at Worcester College.
Pricing Detail
BAS member GBP285; junior member GBP175; student member GBP110; member day rates GBP195 Thursday and GBP145 Friday; non-member GBP430; non-member student GBP220; commercial GBP490; accommodation GBP140 per night; dinner GBP65.
Research Value
Strong abstract and poster routes, invited academic speakers and topic coverage around inflammation, metabolism, oncology and translational science make it useful for research-active trainees.
Trainee Relevance
Student and junior-member fees are available, and the programme includes Young Investigator oral abstracts, scientific poster sessions and a Young Scientist Community session.
Registration Detail
The Wheldon Events form states students need Head of Department proof, speakers are contacted separately, abstract presenters register normally, and registrations after 12 August use the full non-member rate.
Keynote
PM
Prof Matthias Nahrendorf
Harvard Medical School
Leukocytes in cardiovascular health
AF
Amanda Foks
Leiden University
The role of autoimmunity in atherosclerosis
JF
Johan Frostegård
Karolinska Institute
Antibodies against lipids in people with immune-mediated inflammatory diseases and atherosclerosis in population studies
MB
Maya Buch
University of Manchester
Re-purposing rheumatological drug targets for cardiovascular risk reduction
AG
Audrey Gerard
University of Oxford
Plaque destabilisation effects of immune checkpoint inhibitors and other cancer therapies
EL
Esther Lutgens
Mayo Clinic
Effects of immune checkpoint inhibitors in human atherosclerosis
NL
Ninian Lang
University of Glasgow
Management of cardiovascular toxicity of cancer therapies
TV
Toni Vidal-Puig
University of Cambridge
Atherosclerosis and non-alcoholic fatty liver disease
JB
Johan Björkegren
Karolinska Institute
A mechanistic framework for cardiometabolic and coronary artery diseases
LB
Lotte Bjerre Knudsen
Novo Nordisk
GLP1 agonists and reduction of cardiovascular risk
RC
Robin Choudhury
University of Oxford
Trained immunity in diabetes
WM
Willem Mulder
Eindhoven University of Technology
Trained immunity to treat cardiovascular disease
AM
Alastair Moss
AstraZeneca
Use of imaging in cardiovascular drug development
KC
Keith Channon
University of Oxford
Imaging inflammation to guide cardiovascular risk prevention
By CarNot specified on the inspected pages.
ParkingNot specified on the inspected pages.
By TrainThe event page links to University of Oxford visitor travel guidance for getting to Oxford; detailed station instructions were not restated on the BAS page.
Venue DetailsWorcester College, Walton Street, Oxford OX1 2HB. The BAS page lists What3Words as credit.rivers.echo.
Nearest AirportNot specified on the inspected pages.
BAS Annual Meeting 2026 runs at Worcester College, Oxford, from 10 to 11 September 2026 under the theme New branches in atherosclerosis research: from discovery to intervention. It is a research-facing cardiovascular meeting with sessions on cardio-rheumatology, cardiovascular oncology, cardio-metabolism, and bench-to-bedside translation. The speaker list includes the Hugh Sinclair memorial lecture by Prof Matthias Nahrendorf and invited talks from academic, clinical and industry contributors across inflammation, immunology, metabolism, imaging and drug development.
Abstract submission opens on Monday 2 March and closes at 17:00 on Monday 22 June 2026. The BAS page states that shortlisted work can be presented in the Early Career Investigator oral abstract competition or as moderated scientific posters, making the meeting particularly useful for trainees and early-career researchers with atherosclerosis work. Abstracts are submitted as Microsoft Word files, with a 250-word limit and one A4 sheet maximum. No explicit abstract-publication outlet was stated on the inspected pages. Registration opened on Monday 11 May. The standard non-member fee is GBP430; BAS ordinary, senior or honorary members pay GBP285, junior members GBP175 and student members GBP110. Accommodation and dinner are optional paid extras. CPD accreditation and CPD points were not stated.